drugset / Trial / NCT04401527

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite

NCT04401527

Phase 2 Withdrawn Hope Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This multicenter, randomized, double-blind, placebo-controlled clinical trial will evaluate the efficacy and safety of intravenous Sodium Nitrite Injection for treatment of patients infected with COVID-19 who develop lung injury and require mechanical ventilation.

Timeline

Start
2020-07-22
Primary completion
2020-08-15
Completion
2020-08-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Nitrite Small molecule Intravenous